Hostname: page-component-848d4c4894-mwx4w Total loading time: 0 Render date: 2024-06-27T08:29:35.247Z Has data issue: false hasContentIssue false

Immunization against tetanus

Published online by Cambridge University Press:  15 May 2009

J. C. Suri
Affiliation:
School of Bacteriology, University of Melbourne, Parkville, Victoria, Australia
Sydney D. Rubbo
Affiliation:
School of Bacteriology, University of Melbourne, Parkville, Victoria, Australia
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

1. A study of the various aspects of passive tetanus immunization and combined active and passive immunization in different animal species has been undertaken.

2. The criteria on which conclusions have been based consisted of titration of antitoxin serum levels and mouse and guinea-pig protection tests using a challenge of 20 M.L.D. of tetanus toxin.

3. A study of the rate of elimination of heterologous tetanus antitoxin in normal and sensitized animals showed that the latter eliminated antitoxin more rapidly from circulation after subcutaneous injection but no difference could be detected following intravenous administration. More important is the profound loss of serum antitoxin in both animal groups from the seventh day onwards.

4. The rate of elimination in humans receiving 1500 units of horse antitoxin subcutaneously was approximately the same in normal subjects and those who had been previously exposed to horse serum.

5. The interference of an active primary immune response by the simultaneous injection of antitoxin in rabbits was consistently more marked with fluid toxoid than with adsorbed toxoid. Thus, combined active and passive immunization of persons who have never been actively immunized, is not recommended, especially with fluid toxoid.

6. Administration of adsorbed toxoid 7 days or more after passive immunization with heterologous antitoxin does not interfere with the primary immune response.

7. Comparison of the immunizing potency in rabbits of fluid and adsorbed toxoids showed that the latter was far superior.

8. Homologous antitoxin was demonstrated in man and animals to be immunologically superior to the heterologous type in every respect. It persisted unchanged in a therapeutically active concentration for at least 3 weeks in humans and its protective action in guinea-pigs was at least 100 times greater than heterologous antitoxin. Since homologous antitoxin can be used in low doses it will not interfere with the primary immune response in combined immunization.

9. A recommended prophylactic dose of homologous antitoxin for man would be 200–250 units.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1961

References

REFERENCES

Barr, M. & Sachs, A. (1955). Army Pathology Advisory Committee: report on ‘The investiga tion into the prevention of tetanus in the British Army’. War Office.Google Scholar
Cooke, J. V. & Jones, F. G. (1943). The duration of passive tetanus immunity and its effect on active immunization with tetanus toxoid. J. Amer. med. Ass. 121, 1201.CrossRefGoogle Scholar
Dixon, F. J., Bukantz, S. C., Dammin, C. J. & Talmage, D. W. (1951). Fate of I131 labelled bovine gamma globulin in rabbits. Fed. Proc. 10, 553.Google ScholarPubMed
Eckmann, L. (1959). Die Gleichzeitige Anwendung von Serum und Toxoid in der Tetanus Prophylaxe. Schweiz. Med. Woch. 89, 311.Google Scholar
Ericcson, H. (1948). Studies on tetanus prophylaxis. J. clin. Path. 1, 306.CrossRefGoogle Scholar
Gardner, P. A. (1960). Tetanus immunization. Brit. med. J. i, 1277.CrossRefGoogle Scholar
Glenny, A. T. & Hopkins, B. E. (1922). Duration of passive immunity. Part I. J. Hyg., Camb., 21, 142.CrossRefGoogle Scholar
Glenny, A. T. & Hopkins, B. E. (1923). Duration of passive immunity. Part III. J. Hyg., Camb., 22, 37.CrossRefGoogle ScholarPubMed
Glenny, A. T. & Stevens, M. F. (1938). The laboratory control of tetanus prophylaxis. J. R. Army Med. Corps, 70, 308.Google Scholar
Gold, H. & Bachers, H. (1943). Combined active-passive immunization against tetanus. J. Immunol. 47, 335.CrossRefGoogle Scholar
Hunter, W. F. (1959). Tetanus prophylaxis. Med. J. Aust. ii, 98.Google Scholar
Ipsen, J. (1952). The effect of environmental temperature on the immune response of mice to tetanus toxoid. J. Immunol. 69, 273.CrossRefGoogle ScholarPubMed
Littlewood, A. H. M., Mant, A. K. & Wright, G. Payling (1954). Fatal tetanus in a boy after prophylactic tetanus antitoxin. Brit. med. J. ii, 444.CrossRefGoogle Scholar
Madigan, M. R. (1957). Prophylactic value of tetanus antitoxin. Brit. med. J. i, 706.CrossRefGoogle Scholar
Parish, H. J. (1958). Antisera, Toxoids and Vaccines, 4th ed.Edinburgh: E. and S. Livingstone Ltd.Google Scholar
Ramon, C., Boivin, A., Richou, R., Djourichitch, M. & Maccolini, R. (1938). La sèro anatoxithèrapie des toxi-infections en èvolution ses bases expèrimèntals. Rev. d'Immunol., Paris, 4, 24.Google Scholar
Ramon, C., Kourilsky, R., Richou, R. & Kourilsky, S. (1939). Recherches immunologiques sur la sèro-anatoxithèrapie tétanique. Rev. d'Immunol., Paris, 5, 432.Google Scholar
Ramon, G. & Lafaille, A. (1925). Sur l'immunisation antitétanique. C.R. Soc. Biol., Paris, 93, 582.Google Scholar
Ramon, G. & Zoeller, C. (1926). L'immunité et antitétanique par l'anatoxiae chez l'homme. Pr. Med. 31, 485.Google Scholar
Ramon, G. & Zoeller, C. (1927). L'anatoxine tétanique et l'immunisation active de l'homme vis-à.vis du tétanos. Ann. Inst. Pasteur, 41, 803.Google Scholar
Sacqépée, E. & Jude, A. (1937). Sur la valeur et la durée de l'immunité antitétanique après injection de rappel, chex l'homme immunisé. C.R. Soc. Biol., Paris, 125, 711.Google Scholar
Talmage, D. W., Dixon, F. J., Bukantz, S. C. & Dammin, J. G. (1951). Antigen elimination from the blood as an early manifestation of the immune response. J. Immunol. 67, 243.CrossRefGoogle ScholarPubMed
Wadsworth, A. B. (1947). Standard Methods. Baltimore: Williams and Wilkins Co.Google Scholar
Wright, G. Payling.(1958). The use of A.T.S. in the treatment and prophylaxis of tetanus. Proc. R. Soc. Med. 51, 997.Google ScholarPubMed